Abstract:BACKGROUND AND PURPOSE: Vertebrobasilar artery stent placement (VBS) is potentially effective in preventing recurrent posterior circulation strokes; however, the incidences of in-stent restenosis and stented-territory ischemic events based on the location of stent placement have rarely been investigated. We aimed to investigate the characteristics and prognosis of VBS between intracranial and extracranial. MATERIALS AND METHODS: This study was single-center retrospective cohort study, and we obtained medical records of patients who underwent VBS. We compared clinical and periprocedural factors between extracranial and intracranial VBS. The primary outcomes included the incidence of in-stent restenosis (>50% reduction in lumen diameter) and stented-territory ischemic events. We compared the incidence of in-stent restenosis and stented-territory ischemic events by using Kaplan-Meier curves. RESULTS: Of the 105 patients, 41 (39.0%) underwent extracranial VBS, and 64 (61.0%) underwent intracranial VBS. During the follow-up, the incidences of in-stent restenosis and stented-territory ischemic events were 15.2% and 22.9%, respectively. The procedure time was longer (47.7 ± 19.5 minutes versus 74.5 ± 35.2 minutes, P < .001), and the rate of residual stenosis (≥30%) just after VBS was higher (2 [4.9%] versus 24 [37.5%], P < .001) in intracranial VBS than in extracranial VBS. Also, the incidences of in-stent restenosis were significantly higher in intracranial VBS than in extracranial VBS (4.9% versus 21.9%, P = .037). On the other hand, the incidences of stented-territory ischemic events (7.3% versus 32.8%, P < .001) were significantly higher in intracranial VBS than in extracranial VBS. The main mechanisms of stroke were artery-to-artery embolism (2 [66.7%]) in extracranial VBS, and artery-to-artery embolism (9 [42.9%]) and branch atheromatous disease (8 [38.1%]) in intracranial VBS. The Kaplan-Meier curve demonstrated a higher incidence of in-stent restenosis and stented-territory ischemic events in intracranial VBS than in extracranial VBS ( P = .008 and P = .002, respectively). CONCLUSIONS: During the follow-up, the incidence of in-stent restenosis and stented-territory ischemic events was higher in patients with intracranial VBS than in those with extracranial VBS. The higher rates of postprocedural residual stenosis might have contributed to the increased risk of in-stent restenosis. Furthermore, prolonged procedure time and additional stroke mechanism, including branch atheromatous disease, might be associated with a higher risk of stented-territory ischemic events in intracranial VBS.

The Incidence and Risk Factors of In-Stent Restenosis for Vertebrobasilar Artery Stenting

The Long Term Results Of Vertebral Artery Ostium Stenting In A Single Center

Cause Analysis and Treatment of Vertebral Artery Stenosis Angioplasty Restenosis

Predictors of in-stent stenosis and occlusion after endovascular treatment of intracranial vascular disease with the Willis covered stent.

Multiple predictors of in-stent restenosis after stent implantation in symptomatic intracranial atherosclerotic stenosis.

Endovascular Revascularization of Chronically Occluded Vertebral Artery: Single-Center Experience.

Incidence and Predictors of the In-stent Restenosis after Vertebral Artery Ostium Stenting.

Arterial occlusions increase the risk of in-stent restenosis after vertebral artery ostium stenting

Influence of Vessel Size and Tortuosity on In-Stent Restenosis after Stent Implantation in the Vertebral Artery Ostium.

Risk factors for in‐stent restenosis after vertebral artery stenting of V1 segment: A systematic review and meta‐analysis

Effects of the Vertebral Artery Ostium/Subclavian Artery Angle on In-Stent Restenosis after Vertebral Artery Ostium Stenting

Long-Term Risk Factors for Intracranial In-Stent Restenosis from a Multicenter Trial of Stenting for Symptomatic Intracranial Artery Stenosis Registry in China

Risk factors ofrestenosis in postoperative patients with vertebral artery stenosis treated by endovascular stent implantation

Prognosis of Proximal and Distal Vertebrobasilar Artery Stent Placement

The Association Between Cyp2c19 Genotype and of In-Stent Restenosis among Patients with Vertebral Artery Stent Treatment

Predictive Factors for In-stent Restenosis after Balloon-mounted Stent Placement for Symptomatic Intracranial Atherosclerosis

Identifying risk factors for in-stent restenosis in symptomatic intracranial atherosclerotic stenosis: a systematic review and meta-analysis

Risk factors of in-stent restenosis for intracranial artery stenosis: a Meta-analysis

Drug-eluting Stent for the Treatment of Symptomatic Vertebral Origin Stenosis: Long-term Results

Outcome of Endovascular Recanalization for Intracranial In-Stent Restenosis

Long-term outcome of drug-eluting stenting for stenoses of the intracranial vertebrobasilar artery and vertebral ostium.